← FDA Drug Approvals (Drugs@FDA)

OPDIVO QVANTIG

BLA · Biologics License Application · Sponsor: BRISTOL-MYERS SQUIBB · Approved 2024-12-27

Drug application

FDA Application #

BLA761429

Application type

Biologics License Application

Brand name

OPDIVO QVANTIG

Generic name

Nivolumab

Active ingredients

NIVOLUMAB; HYALURONIDASE-NVHY

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

BRISTOL-MYERS SQUIBB

First approval

2024-12-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown